Le Lézard
Classified in: Health
Subjects: RCL, PSF, CFG

Updated Food Recall Warning - Certain Compliments brand and Levitts brand deli meat products recalled due to Listeria monocytogenes


Product photos are available at: https://bit.ly/3afw52L

OTTAWA, ON, Dec. 15, 2020 /CNW/ - The food recall warning issued on December 7, 2020 has been updated to include additional product information. This additional information was identified during the Canadian Food Inspection Agency's (CFIA) food safety investigation.

Levitts Foods (Canada) Inc. is recalling certain Compliments brand and Levitts brand deli meat products from the marketplace due to possible Listeria monocytogenes contamination. Consumers should not consume the recalled products described below.

The following products have been sold in Alberta, Ontario, Quebec, and Nova Scotia and may have been distributed in other provinces and territories.

Recalled products

Brand

Product

Size

UPC

Codes

Compliments

Montreal-Style Smoked Meat

175 g

0 68820 13357 5

BEST BEFORE 2021JA20

EST 48

Levitts

Corned Beef

150 g

8 82756 72084 1

BEST BEFORE 2021JA20

EST 48

Levitts

New York Style Pastrami

150 g

8 82756 73084 0

BEST BEFORE 2021JA20

EST 48

What you should do

If you think you became sick from consuming a recalled product, call your doctor.

Check to see if you have the recalled products in your home. Recalled products should be thrown out or returned to the store where they were purchased.

Food contaminated with Listeria monocytogenes may not look or smell spoiled but can still make you sick. Symptoms can include vomiting, nausea, persistent fever, muscle aches, severe headache and neck stiffness. Pregnant women, the elderly and people with weakened immune systems are particularly at risk. Although infected pregnant women may experience only mild, flu-like symptoms, the infection can lead to premature delivery, infection of the newborn or even stillbirth. In severe cases of illness, people may die.

Background

This recall was triggered by CFIA test results. The CFIA is conducting a food safety investigation, which may lead to the recall of other products. If other high-risk products are recalled, the CFIA will notify the public through updated Food Recall Warnings.

The CFIA is verifying that industry is removing the recalled products from the marketplace.

Illnesses

There have been no reported illnesses associated with the consumption of these products. However, there has been one reported illness that may be associated with the consumption of the products included in the Food Recall Warning of December 7, 2020.

SOURCE Canadian Food Inspection Agency (CFIA)


These press releases may also interest you

at 07:32
Duchesnay Pharmaceutical Group (DPG), one of the eight companies across the country chosen to participate in the Government of Canada's Global Hypergrowth Project, is very proud to announce that it has been awarded the Parity Certificationtm by Women...

at 06:30
The global microscopy market is poised for significant growth, expected to reach USD 10.6 billion by 2029 from USD 8.1 billion in 2024, growing at a CAGR of 5.4%. Key drivers include rising cases of chronic diseases necessitating effective...

at 06:25
Genexine (KOSDAQ: 095700), a publicly-listed, clinical-stage Korean biopharmaceutical company committed to the discovery and development of novel biologics for the treatment of serious unmet medical needs, announced a merger with EPD Biotherapeutics...

at 06:03
The IAMStm brand, proudly part of the Mars family of brands, announced today the launch of the IAMStm Puppy Hub and Kitten Hub, two online tools featuring expert knowledge and advice for new and soon-to-be pet parents. Each Hub will bring...

at 06:00
Today, TELUS Health announced a collaboration with Nova Scotia Health (NSH) to enable residents of Nova Scotia to access their primary care information through the YourHealthNS app. This health data interoperability initiative marks the first...

at 05:30
The global Digital Healthcare Market, valued at $220.10 billion in 2024, is on a trajectory of rapid expansion, with projections indicating it will soar to $836.10 billion by 2031, growing at a compound annual growth rate (CAGR) of 21% from 2024 to...



News published on and distributed by: